Waterhouse, D. N., Sutherland, B. W., Santos, N. D., Masin, D., Osooly, M., Strutt, D., . . . Webb, M. S. (2014). Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities. Invest New Drugs.
Citação norma ChicagoWaterhouse, Dawn N., et al. "Irinophore C™, a Lipid Nanoparticle Formulation of Irinotecan, Abrogates the Gastrointestinal Effects of Irinotecan in a Rat Model of Clinical Toxicities." Invest New Drugs 2014.
Citação norma MLAWaterhouse, Dawn N., et al. "Irinophore C™, a Lipid Nanoparticle Formulation of Irinotecan, Abrogates the Gastrointestinal Effects of Irinotecan in a Rat Model of Clinical Toxicities." Invest New Drugs 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.